What we do

Over the past 51 years, Cure Cancer has raised over $64.7m to support lifesaving research across all cancer types.

We’ve funded over 500 research grants to young researchers with groundbreaking, innovative ideas, and seen many go on to become leaders in cancer research globally.

We support crucial research because we know we won’t cure cancer without it. Our vision is to make this the last generation to die from cancer.

why young researchers?

In today's research environment, funding is incredibly tight, meaning research grants are few and far between. The majority are awarded to scientists who have a proven track record of results, so very few grants are available to young researchers.

This has led to potentially lifesaving research from incredibly talented young minds going unexplored. We’re here to change that.

Cure Cancer funds early-career researchers so that they can advance their research into cancer cures and preventions. Additionally, these grants increase their chances of gaining funding from other grant agencies in the future - over the last ten years our research alumni have attracted on average an additional $45 of future research funding for every dollar we have invested in them.

By identifying, assessing and funding research at a time when ideas burn brightest, we have the best chance of achieving our mission to cure cancer for good.

Cancer Cells.jpg
 
  Dr Antonia Pritchard , 2013-14 grant recipient

Dr Antonia Pritchard, 2013-14 grant recipient

 
Since 1967, we’ve assembled a collective force of brilliant emerging researchers who offer pioneering approaches to overcome cancer in all its forms
 

why do we fund research into all cancer types?

Cancer doesn’t discriminate, which is why Cure Cancer funds crucial research from bright young scientists working across all cancer types.

9.6 million people die from cancer every year worldwide, so we don’t pick and choose the cancers we fight. Our collective team of passionate researchers, donors, fundraisers and partners take on all cancers, including the rarest types.

 
Over the last ten years our research alumni have attracted on average an additional $45 of future research funding for every dollar we have invested in them.
  Prof Roger Reddel , Cure Cancer Australia Alumni

Prof Roger Reddel, Cure Cancer Australia Alumni

Loading...